Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Soluble epoxide hydrolase derived oxylipins as a link between insulin resistance and cognitive progression in patients with type 2 diabetes
FY 2023-24
Summary
Type 2 diabetes mellitus (T2DM) is a serious and prevalent health condition characterized by increased insulin resistance. Insulin resistance is commonly measured using the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR). Individuals with T2DM are more likely than the general population to develop cognitive impairment, and this may be attributable to their increased insulin resistance. The cytochrome P450 oxylipin pathway is a metabolic process in the body which converts dietary fatty acids into epoxides, which are compounds that help resolve inflammation; however soluble epoxide hydrolase (sEH) can further break down these epoxides into less active and potentially harmful species known as diols. This pathway is disrupted in people with T2DM, as they have been found to have more sEH activity resulting in higher serum diol levels, which has also been linked to poorer cognitive performance in this population. This study aims to assess a link between serum oxylipin, (epoxide and diol), levels and the degree of insulin resistance in T2DM, and to understand the relationship between these processes and cognitive decline over time. I hypothesize that serum diol levels will be 1) associated with HOMA-IR at baseline, 2) predict lower cognitive scores over 3-month, 6-month, and 18-month periods, and 3) mediate an effect of HOMA-IR on the decline in cognitive performance over time. This will be a prospective observational study including human participants who have prediabetes or a T2DM diagnosis. This study will offer new insight into the mechanisms that link insulin resistance and cognitive decline over time in T2DM and provide evidence to support pharmacological targets for treatment.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506214
Name
Perfetto Sofia E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Soluble epoxide hydrolase derived oxylipins as a link between insulin resistance and cognitive progression in patients with type 2 diabetes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cognitive Function; Cytochrome P450-Soluble Epoxide Hydrolase; Diols; Epoxides; Homeostatic Model Assessment Of Insulin Resistance; Insulin Resistance; Linear Mixed Model; Oxylipins; Pharmacological Targets; Type 2 Diabetes Mellitus
Abstract
Type 2 diabetes mellitus (T2DM) is a serious and prevalent health condition characterized by increased insulin resistance. Insulin resistance is commonly measured using the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR). Individuals with T2DM are more likely than the general population to develop cognitive impairment, and this may be attributable to their increased insulin resistance. The cytochrome P450 oxylipin pathway is a metabolic process in the body which converts dietary fatty acids into epoxides, which are compounds that help resolve inflammation; however soluble epoxide hydrolase (sEH) can further break down these epoxides into less active and potentially harmful species known as diols. This pathway is disrupted in people with T2DM, as they have been found to have more sEH activity resulting in higher serum diol levels, which has also been linked to poorer cognitive performance in this population. This study aims to assess a link between serum oxylipin, (epoxide and diol), levels and the degree of insulin resistance in T2DM, and to understand the relationship between these processes and cognitive decline over time. I hypothesize that serum diol levels will be 1) associated with HOMA-IR at baseline, 2) predict lower cognitive scores over 3-month, 6-month, and 18-month periods, and 3) mediate an effect of HOMA-IR on the decline in cognitive performance over time. This will be a prospective observational study including human participants who have prediabetes or a T2DM diagnosis. This study will offer new insight into the mechanisms that link insulin resistance and cognitive decline over time in T2DM and provide evidence to support pharmacological targets for treatment.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Perfetto, Sofia E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~